Therapy News and Research

RSS

Penn scientists discover how one inflammatory disorder increases susceptibility to another

The immune system remembers. Often this memory, primed by past encounters with threats like bacteria or viruses, is an asset. But when that memory is sparked by internal drivers, like chronic inflammation, it can prove detrimental, perpetuating a misguided immune response.

27 Apr 2022

Research shows existence of a link between atherosclerotic plaques and the central nervous system

A new research shows the existence of a connection between atherosclerotic plaques and the central nervous system.

27 Apr 2022

The effect of antidepressants on patient-reported health-related quality of life

A new study published in PLoS ONE aimed to investigate the effect of using antidepressant medications on the HRQoL of patients with depression.

27 Apr 2022

Highly Effective Single-Dose HPV Vaccination for the Eradication of Cervical Cancer

In this interview, News-Medical speaks to Dr. Ruanne Barnabas about the KEN She study which found that a single-dose Human Papillomavirus (HPV) vaccination was effective in preventing incident persistent oncogenic HPV infection.

27 Apr 2022

Administration of a lipid reduces inflammation associated with multiple sclerosis in mice

A team led by the Institut de Neurociències at the Universitat Autònoma de Barcelona managed to reduce chronic inflammation associated with multiple sclerosis in mice thanks to the administration of a type of lipid that mediates inflammation.

27 Apr 2022

Chromogranin A plasma levels increase in COVID - predict mortality

A recent paper posted to the Public Library of Science (PLOS) ONE journal showed that plasma levels of chromogranin A (CgA) could predict death in coronavirus disease 2019 (COVID-19) patients.

27 Apr 2022

Researchers reveal how not-yet-malignant cells “turn on” and become metastatic breast cancer

Mount Sinai researchers have discovered a previously unknown mechanism in which not-yet-malignant cells from early breast cancer tumors travel to other organs and, eventually, "turn on" and become metastatic breast cancer.

26 Apr 2022

Roswell Park experts to share latest advances in the treatment of blood-related cancers

Roswell Park Comprehensive Cancer Center specialists will share the latest advances and developments in the treatment of blood-related cancers at the 2022 Tandem Transplantation & Cellular Therapy Meetings of the American Society for Transplantation and Cellular Therapy (ASTCT) and Center for International Blood and Marrow Transplant Research (CIBMTR) in Salt Lake City, Utah, from April 23 to 26.

26 Apr 2022

Moderate fitness levels produce significantly larger immune response in breast cancer survivors

A new study in breast cancer survivors has found that chemotherapy, while a critical part of breast cancer therapy, may also have some lasting dampening effects on natural immunity, but moderate fitness improvements can offer some protection against this effect.

26 Apr 2022

Johns Hopkins scientists receive $7.8 million funding from Break Through Cancer

The Johns Hopkins Kimmel Cancer Center and the Departments of Gynecology/Obstetrics, Neurosurgery and Pathology have been awarded more than $7.8 million for novel, multicenter projects designed to intercept and find cures for several deadly cancers, including pancreatic cancer, ovarian cancer, and the brain cancer known as glioblastoma.

26 Apr 2022

Talking therapies could be effective for treating depression in people with dementia

Feelings of anxiety and depression are common in people living with dementia and mild cognitive impairment, but the best way to treat these symptoms is currently unknown, as medicines often used to treat these symptoms may not be effective for people with dementia and may cause side effects.

26 Apr 2022

Gut virome may warn of a serious and often fatal disease in preterm infants

Immediately after birth, human infants begin to develop a complex, interwoven fabric of microbes in their gut.

26 Apr 2022

Low-cost wireless device could provide precise, safe treatment options for cancers

For those diagnosed with colorectal cancer, surgery has been the only option that offers a solution. Unfortunately, surgery is frequently complicated by disease recurrence at the site of the original cancer when microscopic cancer cells are left behind at the time of surgery.

26 Apr 2022

Nanobody effectively neutralizes pseudotyped ancestral SARS-CoV-2 and Omicron spike proteins

Researchers identified a nanobody inhibiting SARS-CoV-2 variants.

26 Apr 2022

Shopping for space, health systems make over malls

The hulking Hickory Hollow Mall — a full 1.1 million square feet of retail space in southeastern Nashville — was once the largest shopping center in Tennessee. But like many malls, it's been in a downward death spiral for more than a decade.

26 Apr 2022

COVID-19 vaccine can elicit a distinct T cell-dominant immune-mediated hepatitis

In a recent study published in the Journal of Hepatology, researchers reported that the coronavirus disease 2019 (COVID-19) vaccination could elicit a distinct T cell-dominant immune-mediated hepatitis.

25 Apr 2022

ACT-based program is an effective treatment for reducing criminal behavior, study finds

A new study from Iowa State University found men convicted of domestic violence were charged with significantly fewer violent and nonviolent charges one year after completing a treatment program developed in Iowa compared to a model used in most other states.

25 Apr 2022

Odyssean malaria remains a rare event but has potential serious implications

Malaria is mainly a travel-associated infection in Belgium where between 2016 and 2019, 327 to 420 cases were reported annually by the National Reference Laboratory. Local transmission is only sporadically reported.

25 Apr 2022

Common subcutaneous antibody therapy for immunodeficient patients has anti-SARS-CoV-2 antibodies

Researchers at the University of Texas Medical Branch recently confirmed the presence of neutralizing antibodies to SARS--COV-2 in a common subcutaneous antibody therapy (Hizentra) used to treat immunocompromised or immunodeficient patients, citing its protective benefits to the immunocompromised patient community.

25 Apr 2022

Drug-resistant mold found to be spreading and infecting susceptible people's lungs

A new study led by Imperial College London finds that drug-resistant mold is spreading from the environment and infecting susceptible people's lungs.

25 Apr 2022

Therapy News and Research

Penn scientists discover how one inflammatory disorder increases susceptibility to another

Research shows existence of a link between atherosclerotic plaques and the central nervous system

The effect of antidepressants on patient-reported health-related quality of life

Highly Effective Single-Dose HPV Vaccination for the Eradication of Cervical Cancer

Administration of a lipid reduces inflammation associated with multiple sclerosis in mice

Chromogranin A plasma levels increase in COVID - predict mortality

Researchers reveal how not-yet-malignant cells “turn on” and become metastatic breast cancer

Roswell Park experts to share latest advances in the treatment of blood-related cancers

Moderate fitness levels produce significantly larger immune response in breast cancer survivors

Johns Hopkins scientists receive $7.8 million funding from Break Through Cancer

Talking therapies could be effective for treating depression in people with dementia

Gut virome may warn of a serious and often fatal disease in preterm infants

Low-cost wireless device could provide precise, safe treatment options for cancers

Nanobody effectively neutralizes pseudotyped ancestral SARS-CoV-2 and Omicron spike proteins

Shopping for space, health systems make over malls

COVID-19 vaccine can elicit a distinct T cell-dominant immune-mediated hepatitis

ACT-based program is an effective treatment for reducing criminal behavior, study finds

Odyssean malaria remains a rare event but has potential serious implications

Common subcutaneous antibody therapy for immunodeficient patients has anti-SARS-CoV-2 antibodies

Drug-resistant mold found to be spreading and infecting susceptible people's lungs

Evaluating new approaches for rare disease genomics

Expanding access to NMR with the Fourier 80 Duo

Advancing Intracellular Delivery with LumiPore®

Latest News